NASDAQ · Healthcare · Biotechnology
Viridian Therapeutics, Inc.
VRDN
Viridian Therapeutics, Inc. CEO Stephen F. Mahoney · Market cap $1.5B.
$16.63
-0.08 · -0.48%
52w hi $34.2952w lo $13.18
Off 52w high 50.3%
75
STRONG
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
2
1 strong · 1 notable
Analyst consensus
Strong Buy
Avg PT $40.50
Section 01
Recent Form 4 filings
2 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| May 11 | Fairmount Funds Management LLC | Buy | 1,176,470 | $17.00 | +$20.00M | 75 | |
| Oct 23 | Fairmount Funds Management LLC | Buy | 454,545 | $22.00 | +$10.00M | 69 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JulAugSepOctNovDecJanFebMarAprMayJun